Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

10rx vs Brightmeds

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.0

10rx

Best for budget-focused patients who want low-cost compounded GLP-1 with NAD+ and sermorelin add-ons
★★★3.5

Starting at $99.67/mo

Low flat monthly pricingGLP-1 from under $100Free online health quizBoard-certified doctors
Visit 10rx
6.9

Brightmeds

Best for compounded or brand GLP-1 bundled with TRT and peptides for men
★★★3.5

Starting at $325/mo

CompoundedMicrodose OptionsSemaglutideTirzepatide
Visit Brightmeds

Side-by-Side Comparison

Feature10rxBrightmeds
Overall Score7.0/106.9/10
Starting Price$99.67/mo$325/mo
Editorial Rating3.5 ★ /53.5 ★ /5
Features8 features8 features
States Available047
Compounded
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

10rx

What we like

  • Very low pricing — compounded semaglutide $99.67/month and tirzepatide $149.67/month
  • Free online health quiz with board-certified telehealth doctors reviewing eligibility
  • Offers NAD+ and sermorelin alongside GLP-1, for energy and muscle recovery
  • Says it ships to all 50 states with discreet delivery from licensed pharmacy partners

Watch-outs

  • Doesn't publish its legal operating entity, so accountability is hard to verify
  • Pharmacy partners are described as licensed but none are named
  • No terms-of-service page is posted, and FAQ answers load only via script
  • Compounded semaglutide and tirzepatide only — no brand-name or oral options
  • No LegitScript or third-party accreditation is shown on the site

Brightmeds

What we like

  • One login covers GLP-1, TRT, peptides, and longevity — convenient for men exploring weight loss and hormones
  • Offers both compounded GLP-1s and brand-name FDA-approved Zepbound (pens and vials)
  • Microdosing protocols available for compounded semaglutide and tirzepatide
  • Publishes the FDA compounded-medication disclaimer with explicit 503A and 503B facility mention
  • Dispensing pharmacies named in Terms (Beaker Pharmacy and Red Rock Pharmacy)
  • Free baseline labs for TRT clients, and a money-back guarantee if not approved
  • 47-state footprint (excludes AL, AR, MS) — broader than most TRT-focused platforms
  • Tirzepatide is flat-priced across all doses ($289 first month, then $397/mo thereafter) — no extra cost as you titrate up

Watch-outs

  • Pricing isn't itemized on the main pages — you must click through to landers or the application flow
  • Brand-name Zepbound carries a separate $100 doctor consult fee on top of drug cost
  • No LegitScript certification mentioned on the site
  • Named medical director not disclosed
  • Trustpilot rating not independently audited
  • Multi-vertical bundling can distract patients who only want GLP-1
  • $333/mo ongoing compounded semaglutide is mid-to-high; cheaper options start at $149–$249/mo
  • $189 first-month promo is a loss-leader — true ongoing cost is $333/mo (sema) or $397/mo (tirz)

Our Verdict

Winner: 10rxScore: 7.0/10

10rx edges out Brightmeds with a higher overall score of 7.0/10 and is particularly strong for budget-focused patients who want low-cost compounded GLP-1 with NAD+ and sermorelin add-ons. Brightmeds remains a solid alternative, especially if you're looking for compounded or brand GLP-1 bundled with TRT and peptides for men.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Related comparisons

Continue exploring 10rx and Brightmeds head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.